HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Novel 47.5-kb deletion in RAB27A results in severe Griscelli Syndrome Type 2.

Abstract
Griscelli syndrome (GS), a rare autosomal recessive disorder characterized by partial albinism and immunological impairment and/or severe neurological impairment, results from mutations in the MYO5A (GS1), RAB27A (GS2), or MLPH (GS3) genes. We identified a Hispanic patient born of a consanguineous union who presented with immunodeficiency, partial albinism, hepatic dysfunction, hemophagocytosis, neurological impairment, nystagmus, and silvery hair indicative of Griscelli Syndrome Type 2 (GS2). We screened for point mutations, but only exons 2-6 of the patient's DNA could be PCR-amplified. Whole genome analysis using the Illumina 1M-Duo DNA Analysis BeadChip identified a homozygous deletion in the patient's DNA. The exact breakpoints of the 47.5-kb deletion were identified as chr15q15-q21.1: g.53332432_53379990del (NCBI Build 37.1); the patient lacks the promoter and 5'UTR regions of RAB27A, thus confirming the diagnosis of GS2.
AuthorsLisa M Vincent, Fred Gilbert, Jennifer I DiPace, Carla Ciccone, Thomas C Markello, Andrew Jeong, Heidi Dorward, Wendy Westbroek, William A Gahl, James B Bussel, Marjan Huizing
JournalMolecular genetics and metabolism (Mol Genet Metab) Vol. 101 Issue 1 Pg. 62-5 (Sep 2010) ISSN: 1096-7206 [Electronic] United States
PMID20591709 (Publication Type: Case Reports, Journal Article, Research Support, N.I.H., Intramural)
Chemical References
  • rab27 GTP-Binding Proteins
  • RAB27A protein, human
  • rab GTP-Binding Proteins
Topics
  • Base Sequence
  • Humans
  • Immunologic Deficiency Syndromes (genetics)
  • Lymphohistiocytosis, Hemophagocytic
  • Models, Genetic
  • Molecular Sequence Data
  • Mutation
  • Pedigree
  • Piebaldism (genetics)
  • Primary Immunodeficiency Diseases
  • Sequence Deletion (genetics)
  • rab GTP-Binding Proteins (genetics)
  • rab27 GTP-Binding Proteins

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: